People

Sophie Sauvage
Sophie Sauvage is publicly named in the current Belgian official registry as a statutory permanent representative on the Newton Biocapital fund board. This is a specifically qualified fund-governance affiliation rather than an operating investment-team employee or a personal cash check. Newton Biocapital publicly documents this person as Statutory Permanent Representative — Fund I; Statutory Permanent Representative — Fund II. The affiliation is scoped to the published role, with no personal cash investment inferred. Sophie Sauvage is an investment manager in the Q4 2024 WE Life Sciences roster since 2020. Previously worked in corporate finance, auditing and M&A in Luxembourg; holds a HEC-ULiège business-administration degree. The dated public roster does not by itself establish a new employment start day or uninterrupted tenure through October 2026.
Roles
Statutory Permanent Representative — Fund I
Statutory Permanent Representative — Fund II
Investment Manager, Life Sciences — published Q4 2024 roster